panitumumab
UkraineDrugs containing this active substance
-
The drug is prescribed to adults for the treatment of metastatic colorectal cancer, provided that the tumor has a non-mutant (wild-type) RAS gene.
Form: concentrate for infusion solution
Active substance Dosage panitumumab 20 mg/ml ATC: L01FE02
Manufacturer: Amgen Europe B.V. (labeling, secondary packaging and batch release)